The OS in HCC patients with a low expression of ACTG1, CSNK1D, PPP1CC, or BIRC5 was prolonged relative to patients with high expression of ACTG1, CSNK1D, PPP1CC, or BIRC5 (Figure 7(e)). Here, ACTG1 is linked to hepatocellular carcinoma.